NasdaqCM - Delayed Quote USD

Surrozen, Inc. (SRZN)

7.10
+0.25
+(3.65%)
At close: May 16 at 4:00:00 PM EDT
7.10
0.00
(0.00%)
After hours: May 16 at 4:05:11 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
11,638
10,655
0
12,500
0
Operating Expense
37,598
36,194
43,028
56,839
54,391
Operating Income
-25,960
-25,539
-43,028
-44,339
-54,391
Net Non Operating Interest Income Expense
1,604
1,693
2,340
781
72
Other Income Expense
-57,348
-39,718
-2,354
7,554
-329
Pretax Income
-81,704
-63,564
-43,042
-36,004
-54,648
Net Income Common Stockholders
-81,704
-63,564
-43,042
-36,004
-54,648
Diluted NI Available to Com Stockholders
-81,704
-63,564
-43,042
-36,004
-54,648
Basic EPS
-24.86
--
-21.33
-15.60
-33.15
Diluted EPS
-24.86
--
-21.33
-15.60
-33.15
Basic Average Shares
3,319.25
--
2,018
2,314.80
1,645.96
Diluted Average Shares
3,319.25
--
2,018
2,314.80
1,645.96
Total Operating Income as Reported
-25,960
-25,539
-45,780
-44,339
-54,391
Total Expenses
37,598
36,194
43,028
56,839
54,391
Net Income from Continuing & Discontinued Operation
-81,704
-63,564
-43,042
-36,004
-54,648
Normalized Income
-26,004
-63,564
-40,290
-36,004
-54,648
Interest Income
1,604
1,693
2,340
781
72
Net Interest Income
1,604
1,693
2,340
781
72
EBIT
-25,960
-25,539
-43,028
-44,339
-54,391
EBITDA
-24,616
-24,097
-41,117
-42,384
-52,325
Reconciled Depreciation
1,344
1,442
1,911
1,955
2,066
Net Income from Continuing Operation Net Minority Interest
-81,704
-63,564
-43,042
-36,004
-54,648
Total Unusual Items Excluding Goodwill
-55,700
0
-2,752
0
--
Total Unusual Items
-55,700
0
-2,752
0
--
Normalized EBITDA
31,084
-24,097
-38,365
-42,384
-52,325
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 1/11/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ORKA Oruka Therapeutics, Inc.
10.06
+6.34%
 
CALC CalciMedica, Inc.
2.0000
+3.09%
 
AURA Aura Biosciences, Inc.
5.95
+14.86%
 
ENGN enGene Holdings Inc.
3.4500
+1.47%
 
CASI CASI Pharmaceuticals, Inc.
1.9409
+10.28%
 
MTVA MetaVia Inc.
0.6845
+1.29%
 
IVA Inventiva S.A.
3.1100
-10.12%
 
1K0.F IGM Biosciences, Inc.
1.0300
+3.00%
 
HAVLF HAVN Life Sciences Inc.
0.0001
0.00%
 
DB0.F Q32 Bio Inc.
1.5300
+8.51%